High-rolling investors have positioned themselves bullish on SpringWorks Therapeutics SWTX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in SWTX often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 9 options trades for SpringWorks Therapeutics. This is not a typical pattern.
The sentiment among these major traders is split, with 55% bullish and 44% bearish. Among all the options we identified, there was one put, amounting to $54,000, and 8 calls, totaling $534,796.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $45.0 for SpringWorks Therapeutics over the recent three months.
Volume & Open Interest Trends
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in SpringWorks Therapeutics's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to SpringWorks Therapeutics's substantial trades, within a strike price spectrum from $30.0 to $45.0 over the preceding 30 days.
SpringWorks Therapeutics Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| SWTX | CALL | SWEEP | BULLISH | 01/19/24 | $35.00 | $118.3K | 4.0K | 338 |
| SWTX | CALL | TRADE | BULLISH | 06/21/24 | $35.00 | $96.9K | 103 | 100 |
| SWTX | CALL | TRADE | BEARISH | 06/21/24 | $35.00 | $96.0K | 103 | 300 |
| SWTX | CALL | TRADE | BEARISH | 06/21/24 | $35.00 | $88.2K | 103 | 100 |
| SWTX | PUT | SWEEP | BEARISH | 03/15/24 | $40.00 | $54.0K | 103 | 106 |
About SpringWorks Therapeutics
SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
In light of the recent options history for SpringWorks Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of SpringWorks Therapeutics
- Currently trading with a volume of 315,772, the SWTX's price is down by 0.0%, now at $39.5.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 39 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest SpringWorks Therapeutics options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
